Benzinga | May 10, 2021 04:11PM EDT

Mersana Therapeutics Q1 EPS $(0.50) Misses $(0.39) Estimate, Sales $11.00K, Same YoY

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.39) by 28.21 percent. This is a 42.86 percent decrease over losses of $(0.35) per share from the same period last year. The company reported $11.00 thousand in sales this quarter. This is the same as the same period last year.